Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer
ClinicalTrials.gov study NCT01610206. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer
ClinicalTrials.gov study NCT00100815. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT02879318. IPD Sharing: NO. Countries: 1. Publications: 1.
A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer
ClinicalTrials.gov study NCT02237157. IPD Sharing: NO. Countries: 1. Publications: 1.
First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin
ClinicalTrials.gov study NCT00981058. IPD Sharing: Not stated. Countries: 26. Publications: 4.
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer
ClinicalTrials.gov study NCT00361231. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT02077881. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00696696. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer
ClinicalTrials.gov study NCT00247416. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eli
ClinicalTrials.gov study NCT01321541. IPD Sharing: Not stated. Countries: 17. Publications: 2.
High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease
ClinicalTrials.gov study NCT01200329. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT01144455. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
ClinicalTrials.gov study NCT03410030. IPD Sharing: YES. Countries: 1. Publications: 1.
Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine
ClinicalTrials.gov study NCT01978184. IPD Sharing: Not stated. Countries: 1. Publications: 2.
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
ClinicalTrials.gov study NCT00033540. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC
ClinicalTrials.gov study NCT03025880. IPD Sharing: NO. Countries: 1. Publications: 2.
Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer
ClinicalTrials.gov study NCT03451331. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT04677504. IPD Sharing: YES. Countries: 13. Publications: 2.
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
ClinicalTrials.gov study NCT07129993. IPD Sharing: YES. Countries: 8. Publications: 0.
Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT02562898. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.